MRVI logo

MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A

1,035
Mkt Cap
$1.01B
Volume
4.53M
52W High
$4.11
52W Low
$1.95
PE Ratio
-4.35
MRVI Fundamentals
Price
$4.61
Prev Close
$3.94
Open
$4.50
50D MA
$3.36
Beta
1.22
Avg. Volume
1.87M
EPS (Annual)
-$0.9059
P/B
2.70
Rev/Employee
$426,995.40
$777.32
Loading...
Loading...

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available
Poll

Earnings Recap

• Reported GAAP EPS of -$0.02 up 90.48% YoY • Reported revenue of $65.84M up 40.53% YoY • Maravai LifeSciences increased its full year 2026 revenue guidance to $205M to $215M, up from prior. Adjusted EBITDA guidance was also raised to $30M to $32M for 2026.

Bullish

Maravai LifeSciences achieved 40.5% revenue growth to $65.8M in Q1 2026, returned to positive free cash flow, and saw TriLink base non-COVID revenue grow 15% year over year.

Bearish

Maravai faces uncertainty regarding high-volume CleanCap revenue, significant operating result fluctuations, and competition from larger companies developing potentially obsolete technologies, posing risks to future performance.

Latest MRVI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.